B-CELL LYMPHOMA STAGE I

This adverse event was reported 33 times

These drugs are most commonly taken by patients reporting B-CELL LYMPHOMA STAGE I:

# Drug Count
0 METHOTREXATE 5
1 METHOTREXATE SODIUM 5
2 HYDROCHLOROTHIAZIDE 4
3 LENALIDOMIDE 4
4 NATALIZUMAB 4
5 ADALIMUMAB 3
6 INTERFERON BETA-1A 3
7 RITUXIMAB 3
8 ATENOLOL 2
9 CYCLOPHOSPHAMIDE 2
See all common drugs associated with B-CELL LYMPHOMA STAGE I

B-CELL LYMPHOMA STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBRITUMOMAB TIUXETAN 1 0.0007
1 AMOXICILLIN AND CLAVULANATE POTASSIUM 1 0.0002
2 BENAZEPRIL HYDROCHLORIDE 1 0.0001
3 BINIMETINIB 1 0.0001
4 ENCORAFENIB 1 0.0001
5 FELODIPINE 1 0.0001
6 CALCIUM GLUCONATE 1 0.0001
7 DABRAFENIB 1 0.0000
8 PIOGLITAZONE 2 0.0000
9 TRAMETINIB 1 0.0000
See all drugs enriched for association with B-CELL LYMPHOMA STAGE I